Eligible patients were randomised according to a computer-generated global randomisation code in a 3:3:1 ratio to loratadine 10mg once daily, fexofenadine 60mg twice daily, or placebo. Clinic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback